Oncolytics Biotech is trading at $0.94 (up 5.9%) in after-hours trading despite a lack of fresh company-specific news or regulatory updates.
- The stock has experienced a volatile week, including a double-digit gain on July 9 followed by a pullback on July 10.
- The current after-hours strength appears to be driven by normal low-liquidity trading rather than a reaction to new fundamental developments.